ÌÇÐÄ´«Ã½

Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
ÌÇÐÄ´«Ã½

International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).

ÌÇÐÄ´«Ã½

International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version). International journal of radiation oncology, biology, physics Lin, S. J., Guo, Q. J., Liu, Q., Ng, W. T., Ahn, Y. C., AlHussain, H., Chan, A. W., Chow, J., Chua, M., Corry, J., Han, F., Grégoire, V., Harrington, K. J., Hu, C. S., Jensen, K., Langendijk, J. A., Le, Q. T., Lee, N. Y., Lee, V., Lin, J. C., Ma, J., Mendenhall, W. M., O'Sullivan, B., Ozyar, E., Rosenthal, D. I., Tao, Y. G., Wang, R. S., Wee, J., Xu, Z. Y., Yi, J. L., Yom, S. S., Fan, D. M., Mai, H. Q., Pan, J. J., Lee, A. W. 2025

Abstract

Radiotherapy planning for nasopharyngeal carcinoma (NPC) is one of the most challenging tasks for radiation oncologists due to the notoriously narrow therapeutic margin. The first International Guideline (IG-2018 Version) has served as a practical guide for contouring clinical target volumes (CTV). With increasing data on locoregional extension patterns and outcomes from studies on optimizing CTV and doses, an updated International Guideline is pressingly needed to provide a reference for enhancing precision.A comprehensive literature review was conducted to assess existing guidelines and emerging data related to contouring. A preliminary questionnaire was distributed to 30 international experts (from 26 centers in 14 countries/regions) with extensive experience in NPC treatment, aiming to capture diverse practices and opinions. Following initial voting and iterations, a comprehensive survey was prepared for consensus building.The initial questionnaire revealed marked variations in clinical practices related to CTV contouring and prescribed doses among experts. The final Delphi survey consisted of 58 questions: 20 (34%) parameters attained consensus (= 75% agreement) and 32 (55%) attained agreement (60-74% agreement). In the current guideline (IG-2024), 36 parameters involved changes/clarifications compared to IG-2018. The major differences focus on the use of post-induction chemotherapy GTV (except in patients with advanced extranodal extension) for CTV(p/n) to 70 Gy equivalent, stepwise refinement of elective coverage to ipsilateral anatomical structures for eccentric primary tumor, selective coverage of nodal levels, and a lower elective dose of 50 Gy equivalent.Midst the challenges of diverging practices, a comprehensive consensus guideline is devised based on updated evidence and collective agreement among international experts. This serves as a practical reference for optimal target coverage at different dose levels to maximize locoregional control while minimizing toxicities, and guiding principles for generating automated contouring programs to enhance standardization.

View details for

View details for